Clinical Trials Logo

Frailty clinical trials

View clinical trials related to Frailty.

Filter by:

NCT ID: NCT05369962 Recruiting - Frailty Clinical Trials

Adverse Event Prediction in Geriatric Patients in the ED With Ultrasound

AGEDU
Start date: May 10, 2022
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to evaluate whether ultrasound measurements of the Qcsa can be utilized to identify older patients who are at risk for functional decline, ED revisit or death.

NCT ID: NCT05366686 Recruiting - Quality of Life Clinical Trials

The Effect of NICE Support Program on Frailty and Quality of Life in Patients With Heart Failure

NICE
Start date: December 18, 2021
Phase: N/A
Study type: Interventional

This RCT study aims to examine effects of a NICE Support Program in heart failure patients. The following hypotheses were tested: patients who received the NICE program will report significant improvement in frailty , social support, anxiety, and depression, quality of life, and nutritional assessment at baseline,4 weeks, 12 weeks and 24 weeks.

NCT ID: NCT05364879 Recruiting - Ovarian Cancer Clinical Trials

Prehabilitation for Ovarian Cancer Patients

Start date: January 3, 2023
Phase: N/A
Study type: Interventional

Individuals with ovarian cancer have very poor survival rates. This is because the cancer is not usually detected until it has reached advanced stages. How long an individual survives also is determined by the cancer treatment they receive. Although there are best treatment practices to improve survival, some women have other conditions that limit treatment options. One such condition seen in as many as 50% of women with advanced ovarian cancer is frailty (an age-related decline in function and health). This is a major concern as doctors will often have to change how the cancer is treated based on the patient being frail. For example, patients living with frailty are less likely to have their full tumor removed during surgery. They are also more likely to have complications with surgery, stay in the hospital longer, and recover less well from surgery overall. Patients living with frailty also are more likely to experience delays in their chemotherapy starting, receive lower doses of chemotherapy and/or receive fewer cycles of chemotherapy. These changes in treatment may decrease how long a patient survives after diagnosis. Thus, research is needed to explore strategies to decrease frailty in patients who require treatment for advanced ovarian cancer. An option gaining more attention is physical exercise (e.g. walking, repeatedly rising from a chair). Exercise performed before surgery, which is called prehabilitation, can improve how well a patient recovers after surgery and increase how long they survive. Research has shown that prehabilitation is very beneficial for patients undergoing surgery for heart disease. However, it is not clear whether prehabilitation works for those with advanced ovarian cancer that are going to have surgery. Therefore, the investigators want to explore how a 4+ week exercise program performed while waiting for surgery for advanced ovarian cancer changes frailty and how a patient recovers after surgery. The investigators will specifically look whether the exercise program: 1) reduces how frail a patient is before surgery; 2) improves how well the patient recovers after surgery; and 3) affects the patient's chemotherapy treatment plan. This study will provide important information about the ability of prehabilitation exercise to improve surgical and treatment outcomes in women with advanced ovarian cancer. Overall, it is believed that exercise has the potential to improve the survival of advanced ovarian cancer patients.

NCT ID: NCT05350007 Recruiting - Cancer Clinical Trials

Evaluation of Rumination, Frailty and Tanatophobia in Cancer Patients Over 65 Years of Age

CANFRADE
Start date: May 25, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate tanatophobia and rumination in individuals over 65 years of age receiving cancer chemotherapy and to determine the related factors.

NCT ID: NCT05337514 Recruiting - Frailty Clinical Trials

Voice-Activated Technology to Improve Mobility & Reduce Health Disparities (EngAGE)

EngAGE
Start date: October 26, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the efficacy of EngAGE (an interactive, voice-activated app) vs usual care on improving older adult physical and social function.

NCT ID: NCT05335343 Recruiting - Frailty Clinical Trials

Evaluation of the Relationship Between Healthy Eating and Intrinsic Capacity in Elderly Individuals

Start date: April 1, 2022
Phase:
Study type: Observational

The aim of this study is to evaluate the relationship between intrinsic capacity and healthy eating in elderly individuals.

NCT ID: NCT05294757 Recruiting - Sarcopenia Clinical Trials

Development of Continuous Assessment of Frailty and Muscle Quality in Older Subjects: ECOFRAIL Protocol

ECOFRAIL
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

We are conducting a study in different centers in Spain in elderly people, in order to assess the effectiveness of a physical exercise intervention program in people in a situation of frailty. Frailty in an elderly person is a situation in which, although there are no major differences in their usual abilities, the person presents a certain decrease in their capacities. This slight decrease is usually accompanied by a progressive deterioration.

NCT ID: NCT05292989 Recruiting - Clinical trials for Gastrointestinal Diseases

A Personalised Approach Utilising the Frailty Index to Empower Consumers

Start date: August 14, 2023
Phase: N/A
Study type: Interventional

Frailty is a common clinical syndrome in older adults that may carry an increased risk for poor health outcomes including falls, hospitalisation, and mortality. Having a colonoscopy can be associated with potential adverse outcomes in frail patients. At present, however, frailty is not routinely assessed in gastroenterological clinical practice. In a prospective randomised controlled study consenting patients over 65 years at the Princess Alexandra Hospital will receive either a) personalised (tailored) approach that includes assessment of frailty and structured information provided to the consumer or b) current standard practice in regards to having a surveillance colonoscopy to determine the effects on patient satisfaction and percentage of colonoscopies avoided.

NCT ID: NCT05291676 Recruiting - Influenza Clinical Trials

Systems Investigation of Vaccine Responses in Aging and Frailty

Start date: November 6, 2023
Phase: Phase 2
Study type: Interventional

This study will compare the immune response signatures (including immunologic, transcriptomic and metabolomic) of the two influenza vaccines approved for use in adults age 65 and over (Fluad and Fluzone High-Dose).

NCT ID: NCT05284149 Recruiting - Sarcopenia Clinical Trials

Study the Impact of Hirsutella Sinensis Nutrient Supplements Has on Improving Muscle Health and Metabolism in Elderly

HSN
Start date: February 15, 2022
Phase: N/A
Study type: Interventional

Sarcopenia has now been officially recognized as a muscle disease related to aging, which may increase the risk of falls and fractures and both heart and respiratory diseases in the elderly. Sarcopenia causes inconvenience in the elderly, affecting their quality of life and often requiring long-term care or even resulting in death. Moreover, the elderly often encountered malnutrition due to inadequate nutrient intake and scarce nutrient diversity. Furthermore, malnutrition is often one of the leading causes of sarcopenia. Therefore, effective nutritional supplementation is essential to improve or prevent muscle loss for the elderly. Cordyceps sinensis is a well-known valuable traditional Chinese medicine and Hirsutella sinensis was an asexual strain of Cordyceps sinensis. Researchers have found that Hirsutella sinensis can help to increase connection between gastrocnemius muscle fibers and spinal nerve under the amyotrophic lateral sclerosis animal disease model. However, culturing conditions for Hirsutella sinensis are extremely difficult and long, one of the key culturing condition is the temperature, must be maintaining at 16-20℃for 45 days. Fortunately, Grape King Biotech has core technology using liquid fermentation which greatly shortened the cultivation time, thus, providing sufficient and safe products to patients. The investigators designed a randomized placebo-controlled study first to investigate the relationship and clinical impact Hirsutella Sinensis had on muscle mass and function in the elderly. Second, investigate the metabolic impact Hirsutella Sinensis had on muscle mass.